ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Intraoperative Renal Replacement Therapy During Liver and Liver-Kidney Transplant: Outcomes of 155 Cases

    M. Mai,1 E. Golan,2 K. Croome,1 A. Keaveny,1 B. Taner,1 T. Gonwa,1 H. Wadei.1

    1Transplantation, Mayo Clinic, Jacksonville, FL; 2Florida State University, Tallahassee, FL.

    Background: Renal dysfunction in liver (LT) and liver-kidney (LKT) transplant candidates increases intraoperative risks of electrolyte disturbances and volume excess complications. The role of intraoperative…
  • 2015 American Transplant Congress

    Technical Aspects of Reconstruction of Middle Hepatic Vein and Multiple Inferior Right Hepatic Veins Using Dual Artificial Vascular Grafts in Right Lobe Living Donor Liver Transplantation: “V-Plasty” Technique for Common Outflow Reconstruction Vs Second IVC Anastomosis

    P.-C. Li, L. Jeng, A. Thorat, H.-R. Yang, C.-C. Yeh, T.-H. Chen, S.-C. Hsu.

    Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.

    Background:Presence of multiple inferior right hepatic veins (IRHV) along with undrained median sector pose technical difficulties in right lobe living donor liver transplantation (LDLT). Several…
  • 2015 American Transplant Congress

    Kidney Paired Donation: National Activity and Perspectives

    T. Dunn,1 S. Fayek,2 C. Marsh,3 P. Abt.4

    1Surgery, University of Minnesota, Minneapolis, MN; 2Surgery, Rush University Medical Center, Chicago, IL; 3Surgery, Scripps Health, La Jolla, CA; 4Surgery, University of Pennsylvania, Philadelphia, PA.

    While utilization of Kidney Paired Donation (KPD) continues to increase, the potential is not fully realized. We surveyed kidney transplant (KTX) professionals to evaluate perceptions…
  • 2015 American Transplant Congress

    Renal Mass as a Determinant Factor of Long-Term Post-Donation Anemia

    S. Shah,1 B. Lankowsky,2 Z. Zaky,1 S. Nurko,1 R. Fatica,1 S. Gebreselassie,1 B. Stephany,1 E. Poggio.1

    1Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH; 2Case Western Reserve University, SOM, Cleveland, OH.

    Living kidney donors lose approximately 50% of renal mass when donating a kidney however, renal function recovers to within 60-70% of baseline within weeks to…
  • 2015 American Transplant Congress

    Lung Transplant Patients With Elevated Baseline Pulmonary Arterial Pressures Are More Likely to Recover from Post-Transplant Acute Kidney Injury

    B. Stephany,1 E. Wehbe,2 M. Budev.3

    1Nephrology & Hypertension, Cleveland Clinic, Cleveland, OH; 2Nephrology, Wichita, KS; 3Pulmonary, Allergy & Critical Care, Cleveland Clinic, Cleveland, OH.

    Purpose: Elevated pre-operative pulmonary arterial pressures predict acute kidney injury (AKI) after lung transplant. It is unknown if the elevated pulmonary pressures predict recovery from…
  • 2015 American Transplant Congress

    The Impact of Donor and Recipient Weight Incompatibility on Outcomes in Renal Transplantation

    L. Wong,1 S. Moran,1 A. Counihan,2 P. Cunningham,2 P. O'Kelly,1 P. Conlon.1

    1Nephrology, Beaumont Hospital, Dublin, Ireland; 2Urology and Transplantation, Beaumont Hospital, Dublin, Ireland.

    Background: Kidney transplantation has been proposed as an accelerated model of nephron reduction resulting from the accumulation of repeated insults, both immunologic and non-immunologic events.…
  • 2015 American Transplant Congress

    Incidence and Risk Factors of Contrast-Induced Nephropathy in Renal Allograft Recipients

    B. Abu Jawdeh, Y. Sharma, S. Katipally, A. Leonard, R. Alloway, E. Woodle, C. Thakar.

    University of Cincinnati, Cincinnati.

    Background: Contrast-induced nephropathy (CIN) is associated with a significant increase in mortality and morbidity in patients with native kidneys. Data regarding CIN in renal allografts…
  • 2015 American Transplant Congress

    Interrogation of Plasma Cell-Rich Acute Rejection in Human Kidney Allografts by Whole Transcriptome Sequencing

    L. Mesnard, F. Campagne, H. Yang, D. Dadhania, J. Lee, S. Seshan, M. Suthanthiran, T. Muthukumar.

    Weill Medical College of Cornell University, New York.

    Plasma cell-rich acute rejection (PCRAR, plasma cells constituting >20% of the allograft infiltrating cells) portends poor prognosis.To gain better mechanistic insights and develop diagnostic biomarkers,…
  • 2015 American Transplant Congress

    First Dose Tacrolimus Level Is Better Than CYP3A5 Genotyping in Prediction of Target Tacrolimus Dose

    N. Townamchai,1 W. Chancharoenthana,1 S. Wattanatorn,1 S. Vadcharavivad,2 P. Chariyavilaskul,3 A. Leelahavanichkul,4 Y. Avihingsanon,1 K. Praditpornsilpa.1

    1Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; 2Department of Pharmacy Practice, Chulalongkorn University, Bangkok, Thailand; 3Pharmacokinetic Research Unit, Chulalongkorn University, Bangkok, Thailand; 4Department of Microbiology, Chulalongkorn University, Bangkok, Thailand.

    Background: Tacrolimus dose highly varies among Asian kidney transplant recipients. This can be explained by variety of CYP3A5 expression. CYP3A5 genotyping is highly recommended for…
  • 2015 American Transplant Congress

    Liver Fabrication Using Whole Organ Scaffold for Transplantable Graft in Large Animal

    K. Inomata,1 H. Yagi,1 K. Tazima,1 K. Sugiyama,1 M. Hieda,1 T. Hibi,1 Y. Abe,1 M. Kitago,1 M. Shinoda,1 O. Itano,1 T. Akaike,2 Y. Kitagawa.1

    1Surgery, Keio University, Tokyo, Japan; 2Department of Biomolecular Engineering, Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Tokyo, Japan.

    Background and aims: Orthotopic liver transplantation is only effective treatment for end-stage liver disease, however it is limited by shortage of donor livers. Therefore, novel…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences